1-6 of 359 Activities
In this CME Outfitters live webcast, expert faculty will assess the burden of delayed diagnosis on patients with PBC, review evidence-based strategies for early, non-invasive detection, and discuss contemporary clinical pathways for treatment, including recent FDA-approved options. The program will also emphasize interdisciplinary collaboration and shared decision-making to empower patients and improve health outcomes through informed and equitable care. Learners will be equipped with evidence-based tools to help incorporate diagnostic and treatment approaches at the point of care.
In this CME Outfitters live Q&A, expert faculty will answer questions about strategies to enhance health equity in the treatment of ABCD. The focus will be on identifying and mitigating the impact of social drivers of health (SDoH), integrating holistic and culturally congruent care strategies, and employing team-based approaches to ensure equitable treatment outcomes. Learners will gain tools to improve diagnosis, intervention, and long-term care for patients with ABCD, particularly those from high-risk, underserved populations.
In this CME Outfitters live Q&A, expert faculty will discuss actionable strategies to enhance health equity in the management of cardiovascular disorders. The focus will be on identifying and addressing social drivers of health (SDoH) that contribute to disparities, integrating holistic treatment approaches, and employing team-based strategies to ensure equitable care. Learners will gain tools to improve the diagnosis, treatment, and long-term management of hypertension and other cardiovascular conditions, particularly in high-risk, underserved populations.
In this CME Outfitters livestream symposium, expert faculty will review the functions of Fc gamma receptors, CD64 and its connection with IL-23, the molecular attributes of anti–IL-23 therapies, in vivo data on expression of CD64 monocytes, and the most recent clinical trial data differentiating the anti–IL-23 agents. To demonstrate these concepts, animated 3-D models will be included in the educational program and available to attendees.
In this CME Outfitters livestream symposium, expert faculty will guide learners on how to integrate knowledge of the heterogeneity of CD in severity and manifestation into patient assessment and treatment. Learners will be instructed on utilizing alternative diagnostic and evaluation tools beyond colonoscopy for evaluating symptoms in patients with CD. Faculty will model incorporation of histopathologic treatment targets as an objective measure of inflammation in CD to inform clinical decision-making.
In this CME Outfitters live Q&A, expert faculty will answer questions about enhancing mental health care for underserved populations. Focus will be placed on understanding and mitigating the impact of social drivers of health (SDoH), integrating holistic treatment strategies, and employing team-based approaches. Learners will gain tools to improve diagnosis, treatment, and outcomes for racial, ethnic, and LGBTQIA+ groups, fostering equitable mental health care delivery.
Rakesh Jain, MD, MPH, is a Clinical Professor in the department of Psychiatry at the Texas Tech Health Sciences Center School of Medicine – Permian Basin in Midland, Texas and in private practice in Austin, Texas. Dr. Jain attended medical school at the University of Calcutta in India. He received his Master of Public Health (MPH) degree from the University of Texas School of Public Health in Houston, where he was awarded a National Institute/Center for Disease Control Competitive Traineeship. His research thesis focused on the impact of substance abuse.
Dr. Jain completed his residency in psychiatry at the Department of Psychiatry and Behavioral Sciences at the University of Texas Medical School at Houston. He then completed a postdoctoral fellowship in research psychiatry at the University of Texas Mental Sciences Institute in Houston. He was awarded the National Research Service Award in support of his postdoctoral fellowship.
Dr. Jain has been involved in over 100 research projects studying the effects of medications on short-term and long-term treatment of depression, anxiety, pain/mood overlap disorders, ADHD, and psychosis in adult and child/adolescent populations. He has presented at the World Psychiatric Congress held in Prague, and at Depression and Pain Forum meetings internationally. He is the author of 55 articles published in various journals and magazines, such as the Journal of Psychiatric Research and Journal of Clinical Psychiatry, among others, and has presented over 25 original research posters at meetings such as the American Psychological Association (APA), the American College of Neuropsychopharmacology (ACNP), the American Academy of Child and Adolescent Psychiatry (AACAP), the U.S. Psychiatric Congress, and more. He has co-authored six books that range from patient education to cutting-edge neurobiologic findings in psychiatry and mental health. He serves on several advisory boards focusing on drug development and disease state education. He was also recently the Chair of the U.S. Psychiatric Congress, and for several years, has served as a member of the Steering Committee for U.S. Psychiatric Annual Congress. He is a recipient of the Public Citizen of the Year award from the National Association of Social Workers, Gulf Coast Chapter, in recognition of his community and peer education, and championing of mental health issues.
Given the recent position statement from the American Headache Society endorsing calcitonin gene-related peptide receptor antagonists (CGRP-RAs) for first-line prevention of migraine, it is crucial for primary care practitioners to ensure all patients have access to the latest, evidence-based treatments. In this activity, expert faculty will address the educational needs of non-migraine specialist healthcare practitioners. We will discuss common challenges faced by the multidisciplinary care team, including shared decision-making practices to determine the best treatment options for patients.
